TMO Thermo Fisher Scientific Inc

Price (delayed)

$544.81

Market cap

$213.27B

P/E Ratio

28.16

Dividend/share

$1.12

EPS

$19.35

Enterprise value

$243.78B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
The company's equity rose by 17% YoY
Thermo Fisher Scientific's revenue has increased by 15% YoY and by 4.9% from the previous quarter
The debt has soared by 78% YoY but it has decreased by 4.6% QoQ
Thermo Fisher Scientific's quick ratio has decreased by 45% YoY and by 5% from the previous quarter
Thermo Fisher Scientific's gross margin has decreased by 6% YoY and by 3.4% from the previous quarter

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
391.46M
Market cap
$213.27B
Enterprise value
$243.78B
Valuations
Price to earnings (P/E)
28.16
Price to book (P/B)
5.2
Price to sales (P/S)
5.19
EV/EBIT
26.66
EV/EBITDA
20.36
EV/Sales
5.93
Earnings
Revenue
$41.12B
EBIT
$9.14B
EBITDA
$11.97B
Free cash flow
$7.02B
Per share
EPS
$19.35
Free cash flow per share
$17.9
Book value per share
$104.7
Revenue per share
$104.91
TBVPS
$80.73
Balance sheet
Total assets
$92.75B
Total liabilities
$51.73B
Debt
$33.26B
Equity
$40.96B
Working capital
$6.71B
Liquidity
Debt to equity
0.81
Current ratio
1.56
Quick ratio
0.88
Net debt/EBITDA
2.55
Margins
EBITDA margin
29.1%
Gross margin
48.4%
Net margin
18.5%
Operating margin
23.8%
Efficiency
Return on assets
9.2%
Return on equity
19.3%
Return on invested capital
21.5%
Return on capital employed
11.3%
Return on sales
22.2%
Dividend
Dividend yield
0.21%
DPS
$1.12
Payout ratio
5.8%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
0.78%
1 week
8.77%
1 month
-0.73%
1 year
9.98%
YTD
-18.35%
QTD
-7.76%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$41.12B
Gross profit
$19.89B
Operating income
$9.8B
Net income
$7.6B
Gross margin
48.4%
Net margin
18.5%
The net margin has decreased by 16% YoY and by 6% QoQ
Thermo Fisher Scientific's revenue has increased by 15% YoY and by 4.9% from the previous quarter
Thermo Fisher Scientific's operating margin has decreased by 14% YoY and by 7% from the previous quarter
Thermo Fisher Scientific's gross profit has increased by 8% YoY

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
P/E
28.16
P/B
5.2
P/S
5.19
EV/EBIT
26.66
EV/EBITDA
20.36
EV/Sales
5.93
The stock's price to earnings (P/E) is 12% less than its 5-year quarterly average of 31.9
TMO's EPS is down by 3.4% year-on-year
The P/B is 21% above the 5-year quarterly average of 4.3 but 12% below the last 4 quarters average of 5.9
The company's equity rose by 17% YoY
Thermo Fisher Scientific's revenue has increased by 15% YoY and by 4.9% from the previous quarter
The P/S is 12% below the last 4 quarters average of 5.9 but 10% above the 5-year quarterly average of 4.7

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's return on invested capital is down by 29% year-on-year and by 13% since the previous quarter
TMO's ROA is down by 25% YoY and by 10% from the previous quarter
The ROE has contracted by 20% YoY and by 5% from the previous quarter
TMO's ROS is down by 18% year-on-year and by 7% since the previous quarter

Dividends

What is TMO's dividend history
DPS
$1.12
Dividend yield
0.21%
Payout ratio
5.8%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 79% greater than the total liabilities
Thermo Fisher Scientific's total liabilities has soared by 68% YoY but it has decreased by 4.7% from the previous quarter
Thermo Fisher Scientific's quick ratio has decreased by 45% YoY and by 5% from the previous quarter
The debt is 19% lower than the equity
The debt has soared by 78% YoY but it has decreased by 4.6% QoQ
Thermo Fisher Scientific's debt to equity has surged by 53% YoY but it has decreased by 4.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.